Tetracycline and Photosensitivity: Side Effects & Sun Protection

Tetracycline antibiotics — including tetracycline, doxycycline, minocycline, and demeclocycline — are among the most well-recognized causes of drug-induced photosensitivity. They are widely prescribed for acne, rosacea, Lyme disease, respiratory infections, and STIs, making tetracycline photosensitivity one of the most common medication side effects encountered in clinical practice.

Mechanism: How Tetracyclines Cause Photosensitivity

Tetracyclines cause phototoxic reactions — a non-immunological, dose-dependent response requiring no prior sensitization. All patients taking sufficient doses are at risk (unlike photoallergic reactions, which affect only sensitized individuals).

The mechanism:

1. Tetracycline molecules absorb UV-A radiation (315–400nm)
2. The excited tetracycline molecule transfers energy to oxygen in the skin, generating reactive oxygen species (ROS) and singlet oxygen
3. ROS cause direct oxidative damage to cell membranes, DNA, and proteins in sun-exposed skin
4. This produces the characteristic sunburn-like reaction — erythema, edema, blistering — in UV-exposed areas only

Demeclocycline (rarely used now) has the highest photosensitivity risk among tetracyclines. Doxycycline has moderate-to-high photosensitivity risk — clinically significant and commonly encountered. Minocycline has the lowest photosensitivity risk of the common tetracyclines (different metabolic profile). Tetracycline (base compound) has moderate risk.

Clinical Presentation

Tetracycline photosensitivity manifests as:

• Exaggerated sunburn in sun-exposed areas: face, “V” of the neck, forearms, dorsal hands
• Sharp demarcation at clothing lines — only exposed skin affected (distinguishes from allergic reactions)
• Onset within hours of sun exposure
• Erythema, edema, blistering in severe cases
• Onycholysis — separation of the nail plate from the nail bed after photo-activation in the subungual space; characteristic of tetracycline photosensitivity

Facial and eye area involvement can contribute to discomfort and photophobia from periocular skin inflammation, though tetracyclines do not directly cause ocular photophobia in the same way as neurological conditions.

Risk Factors

• Higher doses (acne doses of 100–200mg doxycycline/day have higher risk than 40mg anti-inflammatory dose)
• Extended exposure to UV (outdoor activities, beach, tanning beds)
• Concurrent use of other photosensitizing drugs
• Fair skin phototype (I–II)
• Geographic location and season (peak UV intensity)

Prevention and Management

Sun protection is essential during tetracycline therapy:

• Broad-spectrum sunscreen SPF 50+ with UVA coverage (avobenzone, zinc oxide, titanium dioxide) applied 20 minutes before sun exposure and every 2 hours
• Protective clothing: long sleeves, wide-brim hat, UPF-rated fabric
• Minimize outdoor sun exposure between 10am–4pm
• Avoid tanning beds completely during therapy

If a reaction occurs:

• Topical corticosteroids for erythema and inflammation
• Cool compresses for immediate relief
• For severe reactions: short-course oral prednisone
• Discontinue the tetracycline if reactions are severe or recurrent — discuss alternatives with prescribing physician

Alternative antibiotics with lower photosensitivity risk:

• Minocycline (if tetracycline class required)
• Azithromycin or clarithromycin (for respiratory infections)
• Clindamycin or adapalene (for acne, if topicals suffice)

Important Note: Doxycycline

Doxycycline is by far the most commonly prescribed tetracycline and the one most relevant to clinical photosensitivity concerns. See the separate doxycycline photosensitivity article for detailed guidance specific to doxycycline.

Sources

1. Moore DE. “Drug-induced cutaneous photosensitivity.” Drug Saf. 2002;25(5):345-372.
2. Bjellerup M, Ljunggren B. “Photohaemolytic potency of tetracyclines.” J Invest Dermatol. 1985;84(4):261-263.
3. Gonzalez E, Gonzalez S. “Drug photosensitivity.” J Am Acad Dermatol. 1996;35(6):871-885.